Chiu Christopher, Shin Hyo Jin, Baldwin Hunter T, O'Cleirigh Conall, Mayer Kenneth H, Batchelder Abigail W
Department of Psychiatry, Boston Medical Center, Boston, MA, USA.
Psychology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
J Homosex. 2025 Jul 14:1-20. doi: 10.1080/00918369.2025.2525162.
Sexual minority men (SMM) with HIV who use substances experience multiple forms of stigma (e.g., experienced discrimination) related to aspects of themselves and their behaviors and are disproportionately affected by depression. More research is needed to examine the interrelations between multiple discrimination, including substance-related discrimination, and depression, and the intervening role of substance-related coping among SMM with HIV who use drugs. Self-report data ( = 195) collected between 2017-2018 included experienced discrimination (categories included HIV, sexual orientation, race/ethnicity, substance use), substance-related coping, and depressive symptoms. ANCOVA results revealed significant differences in depressive symptoms based on the number of discrimination categories endorsed, (6,188) = 11.71, < .001, with groups that endorsed discrimination across more stigmatized categories reporting higher depressive symptoms. Supplemental ANCOVA results also indicated differences in depressive symptoms based on endorsement of substance use discrimination, (4,190) = 19.16, < .001. Analysis of indirect associations revealed substance-related coping partially accounted for the relation between multiple discrimination and depressive symptoms, = 1.19, 95%CI [0.58, 1.91]. Results suggest that there is a cumulative association between multiple discrimination and depressive symptoms, and substance-related discrimination and substance-related coping may be particularly important influencers on this association. Multi-level intervention efforts that target multiple discrimination could help ameliorate the high rates of depression in this community.
感染艾滋病毒且使用毒品的性少数男性(SMM)会经历多种形式的污名化(例如,遭受歧视),这些污名化与他们自身及其行为的各个方面相关,并且受抑郁症影响的比例过高。需要更多研究来探讨多种歧视(包括与毒品相关的歧视)与抑郁症之间的相互关系,以及在感染艾滋病毒且使用毒品的性少数男性中,与毒品相关的应对方式所起的干预作用。2017年至2018年收集的自我报告数据(n = 195)包括经历的歧视(类别包括艾滋病毒、性取向、种族/族裔、毒品使用)、与毒品相关的应对方式和抑郁症状。协方差分析结果显示,根据认可的歧视类别数量,抑郁症状存在显著差异,F(6,188) = 11.71,p <.001,认可更多受污名化类别歧视的群体报告的抑郁症状更高。补充协方差分析结果还表明,根据对毒品使用歧视的认可,抑郁症状也存在差异,F(4,190) = 19.16,p <.001。间接关联分析显示,与毒品相关的应对方式部分解释了多种歧视与抑郁症状之间的关系,β = 1.19,95%CI [0.58, 1.91]。结果表明,多种歧视与抑郁症状之间存在累积关联,与毒品相关的歧视和与毒品相关的应对方式可能是这种关联的特别重要的影响因素。针对多种歧视的多层次干预措施可能有助于改善该群体中抑郁症的高发病率。